Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

COVID-19 Update:Learn where you can get your child vaccinated, as well as other important facts about COVID-19.

Newsroom

  • Portrait of Young Girl Patient in Exam Room

    Leader in Care

    Throughout the Washington, D.C, region, the nation and the world, Children’s National Hospital is recognized for our expertise and innovation in pediatric care and as an advocate for all children.

    Read more

Latest News

Eric Vilain, M.D., Ph.D., works in a lab with other researchers.

Children’s National Hospital joins the Mendelian Genomics Research Consortium, receiving $12.8 million

Children’s National Hospital announces a $12.8 million award from the National Institutes of Health’s National Human Genome Research Institute (NHGRI) to establish the Pediatric Mendelian Genomics Research Center (PMGRC) as part of a new Mendelian Genomics Research Consortium. Researchers at Children’s National and Invitae — a leading medical genetics company — will identify novel causes of rare inherited diseases, investigate the mechanisms of undiagnosed conditions, enhance data sharing, and generally interrogate Mendelian phenotypes, which are conditions that run in families.

Children’s National Hospital announces licensing agreement with MGeneRx Inc. for proprietary biometric analysis technology

Children’s National Hospital announces that it has entered into a licensing agreement with MGeneRx Inc. for its patented pediatric medical device technology using objective digital biometric analysis software for the early and non-invasive screening of dysmorphic genetic diseases. The technology was developed by Children’s National to provide a more advanced diagnostic tool for regions of the world with limited access to geneticists or genetic testing. MGeneRx is a spinoff from BreakThrough BioAssets LLC, a life sciences technology operating company focused on accelerating and commercializing new innovations, such as this technology, with an emphasis on positive social impact.
male physician

Nurses graduate with more skill and less debt through Conway Nursing Pathway Program at Children’s National Hospital

Children’s National Hospital announced a second year of success for its Conway Nursing Pathway Program, during a time of heightened stress for health care providers due to the COVID-19 pandemic.The program offers scholarship, mentorship and work study for nurses at all stages of their careers, aiming to deepen career satisfaction and reduce the financial burden of higher education. The result is better care for children from more passionate, experienced nurses.

Childrens National Hospital joins pediatric health challenge led by Center for Advancing Innovation

Reinforcing its commitment to expanding innovation in pediatric care, Children’s National Hospital is joining with the Center for Advancing Innovation (CAI) , and collaborators Resonance Philanthropies and Digital Infuzion, to launch the 2021-2022 Innovate Children’s Health Challenge to encourage the commercialization of technologies that improve children’s health care. This year’s event, Innovate Children’s Health II, focuses on technologies that address pandemic resiliency and prevention in the pediatric population and seeks to advance diagnostics, therapeutics and digital health tools that address pediatric mental health.

Children’s National Hospital welcomes Muller Fabbri, M.D., Ph.D., expert in microRNAs in cancer biology, as associate director of the Center for Cancer and Immunology Research

Children’s National Hospital is pleased to announce it has selected Muller Fabbri, M.D., Ph.D., as associate director for the Center for Cancer and Immunology Research at the Children’s National Research Institute. In this role, he will build and lead the Cancer Biology Program while developing and conducting basic and translational research. Dr. Fabbri will also develop multidisciplinary research projects with various clinical divisions, including oncology, blood and marrow transplantation, pathology and hematology.